MARKET

LFCR

LFCR

Lifecore Biomedical Inc
NASDAQ
6.96
-0.06
-0.85%
After Hours: 7.00 +0.04 +0.57% 16:15 03/06 EST
OPEN
6.92
PREV CLOSE
7.02
HIGH
7.05
LOW
6.65
VOLUME
117.04K
TURNOVER
--
52 WEEK HIGH
8.98
52 WEEK LOW
4.760
MARKET CAP
260.77M
P/E (TTM)
-5.4631
1D
5D
1M
3M
1Y
5Y
1D
Lifecore Sets 2026 Annual Meeting, Proposal Deadlines
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Compass Therapeutics (CMPX) and Shattuck Labs (STTK)
TipRanks · 2d ago
Lifecore Biomedical Signs New Agreement With Indomo For DT-001 In Acne Treatment
NASDAQ · 2d ago
Lifecore, Indomo enter DT-001 development services agreement
TipRanks · 2d ago
Lifecore Biomedical Announces Development Services Agreement To Provide Indomo With CDMO Services To Support Continued Development Of Corticosteroid Drug Candidate, DT-001
Benzinga · 2d ago
Lifecore Biomedical signs development services agreement with Indomo for DT-001 batches
Reuters · 2d ago
LIFECORE BIOMEDICAL SIGNS NEW AGREEMENT WITH INDOMO TO SUPPORT INNOVATIVE DRUG/DEVICE COMBINATION ACNE TREATMENT
Reuters · 2d ago
Weekly Report: what happened at LFCR last week (0223-0227)?
Weekly Report · 5d ago
More
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Webull offers Lifecore Biomedical Inc stock information, including NASDAQ: LFCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LFCR stock methods without spending real money on the virtual paper trading platform.